Liu XY - Search Results

1

Stattic inhibits RANKL-mediated osteoclastogenesis by suppressing activation of STAT3 and NF-κB pathways.

Li CH, Xu LL, Jian LL, Yu RH, Zhao JX, Sun L, Du GH, Liu XY. Li CH, et al. Among authors: liu xy. Int Immunopharmacol. 2018 May;58:136-144. doi: 10.1016/j.intimp.2018.03.021. Epub 2018 Mar 26. Int Immunopharmacol. 2018. PMID: 29587202

2

RANKL downregulates cell surface CXCR6 expression through JAK2/STAT3 signaling pathway during osteoclastogenesis.

Li C, Zhao J, Sun L, Yao Z, Liu R, Huang J, Liu X. Li C, et al. Biochem Biophys Res Commun. 2012 Dec 14;429(3-4):156-62. doi: 10.1016/j.bbrc.2012.10.122. Epub 2012 Nov 7. Biochem Biophys Res Commun. 2012. PMID: 23142594

3

Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL.

Xing R, Zhang Y, Li C, Sun L, Yang L, Zhao J, Liu X. Xing R, et al. Int J Mol Med. 2016 Oct;38(4):1125-34. doi: 10.3892/ijmm.2016.2722. Epub 2016 Aug 30. Int J Mol Med. 2016. PMID: 27599586 Free PMC article.

4

Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα.

Ma Z, Yu R, Zhao J, Sun L, Jian L, Li C, Liu X. Ma Z, et al. Inflamm Res. 2019 Feb;68(2):157-166. doi: 10.1007/s00011-018-1209-9. Epub 2019 Jan 2. Inflamm Res. 2019. PMID: 30604211

5

CXCL16/CXCR6 axis promotes bleomycin-induced fibrotic process in MRC-5 cells via the PI3K/AKT/FOXO3a pathway.

Ma Z, Yu R, Zhu Q, Sun L, Jian L, Wang X, Zhao J, Li C, Liu X. Ma Z, et al. Int Immunopharmacol. 2020 Apr;81:106035. doi: 10.1016/j.intimp.2019.106035. Epub 2019 Nov 19. Int Immunopharmacol. 2020. PMID: 31753588

6

AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis.

Li CH, Zhao JX, Sun L, Yao ZQ, Deng XL, Liu R, Liu XY. Li CH, et al. Among authors: liu xy, liu r. Biochem Biophys Res Commun. 2013 Jun 14;435(4):533-9. doi: 10.1016/j.bbrc.2013.04.084. Epub 2013 May 7. Biochem Biophys Res Commun. 2013. PMID: 23665018

7

CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2/STAT3 and p38/MAPK signaling pathway.

Li CH, Xu LL, Zhao JX, Sun L, Yao ZQ, Deng XL, Liu R, Yang L, Xing R, Liu XY. Li CH, et al. Among authors: liu xy, liu r. Inflamm Res. 2016 Mar;65(3):193-202. doi: 10.1007/s00011-015-0905-y. Epub 2015 Nov 30. Inflamm Res. 2016. PMID: 26621504

8

Iguratimod inhibits osteoclastogenesis by modulating the RANKL and TNF-α signaling pathways.

Li CH, Ma ZZ, Jian LL, Wang XY, Sun L, Liu XY, Yao ZQ, Zhao JX. Li CH, et al. Among authors: liu xy. Int Immunopharmacol. 2021 Jan;90:107219. doi: 10.1016/j.intimp.2020.107219. Epub 2020 Dec 9. Int Immunopharmacol. 2021. PMID: 33307512

9

Interleukin-21 enhances Toll-like receptor 2/4-mediated cytokine production via phosphorylation in the STAT3, Akt and p38 MAPK signalling pathways in human monocytic THP-1 cells.

Jian L, Sun L, Li C, Yu R, Ma Z, Wang X, Zhao J, Liu X. Jian L, et al. Scand J Immunol. 2019 Jun;89(6):e12761. doi: 10.1111/sji.12761. Epub 2019 Apr 11. Scand J Immunol. 2019. PMID: 30977163 Free article.

10

Identification and suppression of epidermal growth factor receptor variant III signaling in fibroblast-like synoviocytes from aggressive rheumatoid arthritis by the mimotope.

Niu J, Li C, Jin Y, Xing R, Sun L, Yu R, Jian L, Liu X, Yang L. Niu J, et al. Immunol Lett. 2018 Jun;198:74-80. doi: 10.1016/j.imlet.2018.04.009. Epub 2018 Apr 27. Immunol Lett. 2018. PMID: 29709544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,105 results

Search Page

Filters